Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Radiofrequency Ablation Use in Thyroid Nodule

NCT05003856 is registered in ClinicalTrials.gov with M.D. Anderson Cancer Center as lead sponsor.

NCT NCT05003856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05003856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Radiofrequency Ablation Use in Thyroid Nodule
Lead sponsor
M.D. Anderson Cancer Center
Phase
Not applicable
Overall status
Terminated
Start date
August 29, 2022
Completion date
March 27, 2025
Enrollment
1 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

benign thyroid gland neoplasm, recurrent thyroid gland carcinoma, thyroid gland follicular tumor of uncertain malignant potential, thyroid gland nodule, thyroid gland papillary carcinoma